Biogen, the company behind the embattled Alzheimer’s drug Aduhelm, has hired a new lobbyist focused on Alzheimer’s advocacy, but he’s not necessarily the type of expert you’d expect. In fact, he doesn’t represent any other drug makers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,